Saturday 17 October 2026
Export BDRX’s income statement to Excel — free account
Biodexa Pharmaceuticals PLC Unsponsored ADR
BDRX Healthcare Biotechnology
Biodexa Pharmaceuticals PLC Unsponsored ADR’s revenue for fiscal 2023 (year ended December 2023) was $473,900.00, down 45.2% from fiscal 2022.
0.46
0.03
+6.98%
Follow BDRX
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
4 | 3 | 5 | 3 | 3 | 3 | — | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Altman Z-Score |
200,992,346.21 | 68,807,665.57 | 6,049,495.26 | 1,046,959.33 | 4,831,870.25 | 5,997,840.00 | — | (21.37) | — | — |
P/S ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Altman Z″-Score (non-manufacturers) |
(1.15) | (3.48) | (12.13) | (9.47) | (49.95) | (26.41) | (86.00) | (48.13) | — | — |
Beneish M-Score |
(0.76) | (2.75) | (0.61) | (2.90) | (9.50) | (1.52) | (3.48) | 100.49 | — | — |
P/Operating CF |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
EV/Sales |
0.00 | 0.00 | 0.00 | 0.00 | (14.51) | (12.26) | (1.67) | (4.70) | — | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.36 | 0.60 | 0.14 | 0.34 | — | — |
EV/Operating CF |
0.37 | 0.15 | 0.03 | 0.15 | 0.27 | 0.38 | 0.11 | 0.26 | — | — |
EV/FCF |
0.34 | 0.14 | 0.02 | 0.14 | 0.26 | 0.37 | 0.10 | 0.26 | — | — |
Quick Ratio |
2.30 | 2.11 | 2.27 | 2.42 | 3.10 | 6.39 | 2.47 | 1.26 | 1.75 | 2.03 |
Current Ratio |
2.39 | 2.22 | 2.27 | 2.42 | 3.10 | 6.39 | 2.47 | 1.26 | 1.75 | 2.03 |
Net Debt/EBITDA |
0.59 | 0.44 | 0.11 | 0.48 | 0.33 | 1.41 | 0.26 | 0.71 | 0.11 | 1.00 |
Debt/Assets |
3.81% | 13.30% | 6.12% | 19.69% | 2.65% | 5.93% | 11.29% | 4.40% | 4.92% | 0.34% |
Debt/Equity |
0.05 | 0.19 | 0.07 | 0.31 | 0.04 | 0.07 | 0.20 | 0.10 | 0.09 | 0.01 |
Asset Turnover |
0.11 | 0.14 | 0.06 | 0.03 | 0.02 | 0.05 | 0.07 | 0.05 | 0.00 | 0.00 |
Operating CF/Net income |
0.65 | 0.81 | 0.89 | 0.64 | 0.42 | 1.10 | 0.92 | 0.96 | 2.14 | 0.88 |
Capex/Depreciation |
(0.31) | (0.58) | (0.15) | (0.25) | (0.05) | (0.69) | (0.12) | (0.92) | (3.05) | (3.56) |
Interest Coverage |
(419.14) | (105.91) | (20.13) | (116.64) | (53.46) | (159.06) | (168.41) | (195.46) | (55.74) | (37.75) |
| (40.89%) | (38.82%) | (59.64%) | (54.15%) | (169.59%) | (65.29%) | (103.59%) | (181.00%) | (88.99%) | (65.58%) | |
| (31.27%) | (29.52%) | (44.22%) | (38.59%) | (109.46%) | (49.46%) | (77.02%) | (88.29%) | (45.76%) | (39.28%) | |
ROIC |
(63.14%) | (39.21%) | (46.64%) | (48.08%) | 0.00% | (376.70%) | (587.61%) | 0.00% | (77.90%) | (184.28%) |
Return on Tangible Assets |
(128.22%) | (126.00%) | (292.98%) | (98.64%) | (324.97%) | (49.31%) | (211.55%) | (348.38%) | (139.73%) | (99.67%) |
Average Days of Receivables |
204.46 | 213.20 | 616.82 | 1,521.24 | 1,839.92 | 1,076.08 | 967.04 | 1,014.59 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
96.55% | 134.05% | 482.93% | 1,163.69% | 1,769.14% | 805.20% | 731.18% | 1,067.50% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
270.77% | 165.37% | 226.73% | 617.82% | 1,445.53% | 509.69% | 649.78% | 1,139.69% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.55 | 0.56 | 0.61 | 0.40 | 0.00 | 0.00 | 0.00 | 0.28 | 0.38 | 0.31 |
Share Based Compensation of Revenue |
2.93% | 6.84% | (1.86%) | (5.04%) | (117.78%) | 15.40% | 17.59% | 7.34% | 0.00% | 0.00% |
Graham Net Nets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Earnings Yield |
(47.93%) | (103.94%) | (19.16%) | (63.75%) | 0.00% | 0.00% | 0.00% | (0.08%) | — | — |
Free Cash Flow Yield |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — | — |
Revenue per Share |
0.52 | 0.38 | 0.85 | 0.23 | 0.05 | 0.05 | 0.00 | 789.83 | 0.00 | 0.00 |
Operating CF per Share |
(0.98) | (0.65) | (5.87) | (2.26) | (1.39) | (0.51) | 0.00 | (14,151.50) | (1,582.66) | (67.21) |
Capex per Share |
(0.10) | (0.07) | (0.10) | (0.11) | (0.01) | (0.02) | 0.00 | (537.00) | (99.91) | (8.09) |
Free Cash Flow per Share |
(1.09) | (0.73) | (5.97) | (2.37) | (1.40) | (0.54) | 0.00 | (14,688.50) | (1,682.57) | (75.30) |
Cash per Share |
1.32 | 0.66 | 1.02 | 3.81 | 1.13 | 0.86 | 0.00 | 12,378.83 | 215.43 | 102.59 |
Shareholders Equity per Share |
3.44 | 1.74 | 7.39 | 6.81 | 1.01 | 0.89 | 0.00 | 9,698.33 | 1,074.21 | 137.10 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
3.44 | 1.74 | 7.39 | 6.81 | 1.01 | 0.89 | 0.00 | 9,698.33 | 1,074.21 | 137.10 |
Free Cash Flow |
(19.59) | (18.61) | (18.25) | (8.69) | (12.03) | (8.64) | (8.77) | (8.81) | (16.66) | (8.26) |
Working Capital |
17.56 | 13.17 | 4.20 | 10.30 | 8.07 | 13.64 | 3.45 | 1.82 | 4.83 | 8.33 |
Capital Expenditures |
(1.85) | (1.91) | (0.29) | (0.41) | (0.08) | (0.38) | (0.05) | (0.32) | (0.99) | (0.89) |
Net Current Asset Value |
15.37 | 5.20 | 2.80 | 3.06 | 7.93 | 12.79 | 2.88 | 1.45 | 3.01 | 7.48 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Capex to Sales |
0.20 | 0.20 | 0.11 | 0.47 | 0.19 | 0.48 | 0.06 | 0.68 | 0.00 | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
1.57 | 1.01 | 0.73 | 0.60 | 2.25 | 0.35 | 0.41 | 0.50 | 0.78 | 2.08 |
Cash ROIC |
(22.07%) | (26.53%) | (66.62%) | (18.62%) | (64.49%) | (29.55%) | (107.07%) | (63.75%) | (121.62%) | (31.32%) |
Accounts Receivable Turnover |
1.72 | 1.78 | 0.51 | 0.22 | 0.15 | 0.35 | 0.37 | 0.26 | 0.00 | 0.00 |
Accounts Payable Turnover |
0.08 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
1.00 | 1.03 | 0.00 | — | — | — | — | — | — | — |
Average Days of Payables |
4,600.45 | 3,154.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
447.08 | 370.93 | 0.00 | — | — | — | — | — | — | — |
Average Receivables |
5.45 | 5.49 | 5.05 | 3.98 | 2.90 | 2.28 | 2.32 | 1.80 | 5.22 | 7.14 |
Average Payables |
11.11 | 10.85 | 6.56 | 4.27 | 3.66 | 1.54 | 1.65 | 1.67 | 3.01 | 3.95 |
Average Inventory |
0.90 | 1.16 | 0.83 | — | — | — | — | — | — | — |
Average Assets |
87.37 | 70.14 | 45.36 | 33.37 | 26.03 | 15.18 | 12.30 | 9.97 | 16.00 | 21.43 |
Average Common Equity |
66.83 | 53.33 | 33.64 | 23.78 | 16.80 | 11.50 | 9.14 | 4.87 | 8.23 | 12.84 |
Columns are period end dates